Does BREXUCABTAGENE AUTOLEUCEL Cause Cytokine release syndrome? 827 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 827 reports of Cytokine release syndrome have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 47.3% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
827
Reports of Cytokine release syndrome with BREXUCABTAGENE AUTOLEUCEL
47.3%
of all BREXUCABTAGENE AUTOLEUCEL reports
168
Deaths
436
Hospitalizations
How Dangerous Is Cytokine release syndrome From BREXUCABTAGENE AUTOLEUCEL?
Of the 827 reports, 168 (20.3%) resulted in death, 436 (52.7%) required hospitalization, and 97 (11.7%) were considered life-threatening.
Is Cytokine release syndrome Listed in the Official Label?
Yes, Cytokine release syndrome is listed as a known adverse reaction in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Disease progression (93)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
Encephalopathy (53)
What Other Drugs Cause Cytokine release syndrome?
AXICABTAGENE CILOLEUCEL (4,140)
CYCLOPHOSPHAMIDE (2,263)
TISAGENLECLEUCEL (1,660)
FLUDARABINE (1,458)
RITUXIMAB (1,404)
BLINATUMOMAB (952)
DEXAMETHASONE (853)
DOXORUBICIN (850)
VINCRISTINE (771)
PREDNISONE (706)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Cytokine release syndrome Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE